CAPA In-vitro Oocyte Maturation

NANot yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

May 31, 2030

Study Completion Date

May 31, 2032

Conditions
Infertility, Female
Interventions
PROCEDURE

CAPA IVM

In CAPA-IVM, the oocyte is treated and matured outside the woman's body, while in classical IVF, the patient is treated. As a consequence, patients undergoing CAPA-IVM are not confronted with the typical risks and burden of systemic ovarian stimulation.

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT06984081 - CAPA In-vitro Oocyte Maturation | Biotech Hunter | Biotech Hunter